Testosterone therapy in HIV wasting syndrome: systematic review and meta-analysis.

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Lancet. Infectious Diseases (Print)

• Publication date

  2002-11-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/S1473-3099(02)00441-3PMID 12409050
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Treatment guidelines for HIV-associated wasting.

  2000cited by this paper
• Testosterone replacement and resistance exercise in HIV-infected men with weight loss and low testosterone levels.

  2000cited by this paper
• DHEA treatment for HIV+ patients: effects on mood, androgenic and anabolic parameters.

  2000cited by this paper
• Thalidomide for the Treatment of AIDS-Associated Wasting

  2000cited by this paper
• Effects of Testosterone and Progressive Resistance Training in Eugonadal Men with AIDS Wasting

  2000cited by this paper
• A double-blind, placebo-controlled trial of testosterone therapy for HIV-positive men with hypogonadal symptoms.

  2000cited by this paper
• Treatment guidelines for HIV-associated wasting.

  2000cited by this paper
• Effects of testosterone and progressive resistance training in eugonadal men with AIDS wasting. A randomized, controlled trial.

  2000cited by this paper
• Effects of pharmacological doses of nandrolone decanoate and progressive resistance training in immunodeficient patients infected with human immunodeficiency virus.

  1999cited by this paper
• Testosterone therapy for human immunodeficiency virus-positive men with and without hypogonadism.

  1999cited by this paper
• Short-term progressive resistance training increases strength and lean body mass in adults infected with human immunodeficiency virus.

  1999cited by this paper
• Resistance exercise and supraphysiologic androgen therapy in eugonadal men with HIV-related weight loss: a randomized controlled trial.

  1999cited by this paper
• Diagnosis, prediction, and natural course of HIV-1 protease-inhibitor-associated lipodystrophy, hyperlipidaemia, and diabetes mellitus: a cohort study.

  1999cited by this paper
• The use of a transscrotal testosterone delivery system in the treatment of patients with weight loss related to human immunodeficiency virus infection.

  1999cited by this paper
• Monitoring changes in fat-free mass in HIV-positive men with hypotestosteronemia and AIDS wasting syndrome treated with gonadal hormone replacement therapy.

  1999cited by this paper
• Sustained anabolic effects of long-term androgen administration in men with AIDS wasting.

  1999cited by this paper
• Effects of nandrolone decanoate therapy in borderline hypogonadal men with HIV-associated weight loss.

  1999cited by this paper
• Effects of testosterone on weight and body composition in men with human immunodeficiency virus-related weight loss

  1999cited by this paper
• Beneficial effects of protease inhibitors on body composition and energy expenditure: a comparison between HIV-infected and AIDS patients.

  1999cited by this paper
• The effect of protease inhibitors on weight and body composition in HIV‐infected patients

  1998cited by this paper
• Thalidomide pros and cons.

  1998cited by this paper
• Effects of testosterone replacement with a nongenital, transdermal system, Androderm, in human immunodeficiency virus-infected men with low testosterone levels.

  1998cited by this paper
• Effects of Androgen Administration in Men with the AIDS Wasting Syndrome

  1998cited by this paper
• The etiology of wasting in the human immunodeficiency virus and acquired immunodeficiency syndrome.

  1998cited by this paper
• Transdermal testosterone administration in women with acquired immunodeficiency syndrome wasting: a pilot study.

  1998cited by this paper
• New Classification System Recognized

  1998cited by this paper
• Testosterone replacement increases fat-free mass and muscle size in hypogonadal men.

  1997cited by this paper
• A trial of testosterone therapy for HIV‐associated weight loss

  1997cited by this paper
• Effects of testosterone replacement on muscle mass and muscle protein synthesis in hypogonadal men--a clinical research center study.

  1996cited by this paper
• Loss of lean body and muscle mass correlates with androgen levels in hypogonadal men with acquired immunodeficiency syndrome and wasting.

  1996cited by this paper
• Safety and efficacy of nandrolone decanoate for treatment of wasting in patients with HIV infection

  1996cited by this paper
• Recombinant human growth hormone, insulin-like growth factor 1, and combination therapy in AIDS-associated wasting. A randomized, double-blind, placebo-controlled trial.

  1996cited by this paper
• The effects of supraphysiologic doses of testosterone on muscle size and strength in normal men.

  1996cited by this paper
• Oxandrolone in AIDS‐wasting myopathy

  1996cited by this paper
• Recombinant Human Growth Hormone in Patients with HIV-Associated Wasting

  1996cited by this paper
• Recombinant Human Growth Hormone, Insulin-like Growth Factor 1, and Combination Therapy in AIDS-Associated Wasting

  1996cited by this paper
• Effects of thalidomide on HIV‐associated wasting syndrome: a randomized, double‐blind, placebo‐controlled clinical trial

  1996cited by this paper
• Recombinant human growth hormone in patients with HIV-associated wasting. A randomized, placebo-controlled trial. Serostim Study Group.

  1996cited by this paper
• Testosterone replacement therapy improves mood in hypogonadal men--a clinical research center study.

  1996cited by this paper
• The effects of supraphysiologic doses of testosterone on muscle size and strength in normal men.

  1996cited by this paper
• Oxymetholone promotes weight gain in patients with advanced human immunodeficiency virus (HIV-1) infection

  1996cited by this paper
• Effects of megestrol acetate therapy on body composition and circulating testosterone concentrations in patients with AIDS.

  1995cited by this paper
• Early changes of body composition in human immunodeficiency virus-infected patients: tetrapolar body impedance analysis indicates significant malnutrition.

  1993cited by this paper
• The five-level model: a new approach to organizing body-composition research.

  1992cited by this paper
• Megestrol acetate for treatment of anorexia and cachexia associated with human immunodeficiency virus infection.

  1990cited by this paper
• Changes in the hypothalamic-pituitary-gonadal axis in human immunodeficiency virus-infected homosexual men.

  1989cited by this paper
• Magnitude of body-cell-mass depletion and the timing of death from wasting in AIDS.

  1989cited by this paper
• Nutritional status, gastrointestinal dysfunction, and survival in patients with AIDS.

  1989cited by this paper
• Endocrine disorders in men infected with human immunodeficiency virus.

  1988cited by this paper
• Megestrol acetate for treatment of cachexia associated with human immunodeficiency virus (HIV) infection.

  1988cited by this paper
• Body composition studies in patients with the acquired immunodeficiency syndrome.

  1985cited by this paper
• The Journal of Clinical Endocrinology & Metabolism Printed in U.S.A. Copyright © 1999 by The Endocrine Society Serum Leptin Response to the Acute and Chronic Administration of Growth Hormone (GH) to Elderly Subjects with GH Deficiency*

  year unknowncited by this paper

• Title: Updates on Testosterone Deficiency in Men Living With HIV and the Cardiovascular Implications

  2024cites this paper
• Testosterone replacement therapy in patients with cachexia: a contemporary review of the literature.

  2024cites this paper
• The anabolic applications of androgens in older adults with functional limitations.

  2022cites this paper
• Testosterone Treatment As a Function-Promoting Therapy in Sarcopenia Associated with Aging and Chronic Disease.

  2022cites this paper
• Therapeutic effects of androgens for cachexia.

  2021cites this paper
• Testosterone, HIV, and cardiovascular disease risk

  2020cites this paper
• Testosterone and male rejuvenation.

  2019cites this paper
• ASHP Guidelines on Pharmacist Involvement in HIV Care

  2019cites this paper
• Testosterone replacement therapy: For whom, when and how?

  2018cites this paper
• Patient Care : Specific Practice Areas – Guidelines ASHP Guidelines on Pharmacist Involvement in HIV Care

  2018cites this paper
• Testosterone Therapy in Men With Hypogonadism: An Endocrine Society Clinical Practice Guideline.

  2018influential citation
• Effects of Testosterone Supplementation on Body Composition in HIV Patients: A Meta-analysis of Double-blinded Randomized Controlled Trials

  2018cites this paper
• Testosterone and Physical Function

  2017cites this paper
• Highly Active Antiretroviral Therapy-Associated Metabolic Syndrome and Lipodystrophy: Pathophysiology and Current Therapeutic Interventions

  2017cites this paper
• Hypogonadism in the HIV-Infected Man

  2017cites this paper
• Testosterone supplementation and body composition : results from a meta-analysis study

  2016cites this paper
• ASHP Guidelines on Pharmacist Involvement in HIV Care.

  2016cites this paper
• THERAPY OF ENDOCRINE DISEASE: Testosterone supplementation and body composition: results from a meta-analysis study.

  2016cites this paper
• Effects of Progressive Resistance Exercises on Quality of Life, Body Composition and Muscle Strength in Patients with HIV

  2015cites this paper
• Effects of Progressive Resistance Exercises on Quality of Life, Body Composition and Muscle Strength in Patients with HIV (Kesan Latihan Rintangan Progresif terhadap Kualiti Hidup, Komposisi Tubuh dan Kekuatan Otot dalam Kalangan Pesakit HIV)

  2015cites this paper
• Testosterone and obesity

  2015cites this paper
• Hypogonadism in Human Immunodeficiency Virus-Positive Men

  2014cites this paper
• ' s response to reviews Title : Testosterone therapy and cardiovascular events among men : a systematic review and meta-analysis of placebo-controlled randomized trials

  2013cites this paper
• Testosterone therapy and cardiovascular events among men: a systematic review and meta-analysis of placebo-controlled randomized trials

  2013cites this paper
• Testosterone Replacement Therapy in Men With Hypogonadism and HIV/AIDS: Results From the TRiUS Registry

  2013cites this paper
• Optimal Diagnostic Measures and Thresholds for Hypogonadism in Men With HIV/AIDS: Comparison Between 2 Transdermal Testosterone Replacement Therapy Gels

  2013cites this paper
• Male hypogonadism and testosterone replacement therapy

  2013cites this paper
• HIV and Testosterone in Men

  2013cites this paper
• testosterone, cardiovascular, men, trial

  2013cites this paper
• National Athletic Trainers' Association position statement: anabolic-androgenic steroids.

  2012cites this paper
• Testosterone: List of Contributors

  2012cites this paper
• Meeting report Report on the Second Endocrine Aspects of Duchenne Muscular Dystrophy Conference December 1-2, 2010, Baltimore, Maryland, USA

  2011cites this paper
• Report on the Second Endocrine Aspects Of Duchenne Muscular Dystrophy Conference December 1-2, 2010, Baltimore, Maryland, USA.

  2011cites this paper
• Androgen Effects on the Skeletal Muscle

  2010cites this paper
• CLINICAL PRACTICE GUIDELINE Testosterone Therapy in Adult Men with Androgen Deficiency Syndromes: An Endocrine Society Clinical Practice Guideline

  2010cites this paper
• Endocrine Society Clinical Practice Guideline Testosterone Therapy in Men with Androgen Deficiency Syndromes: An

  2010cites this paper
• Summary of Recommendations 1 . 1 Diagnosis and evaluation of patients with suspected androgen deficiency

  2010cites this paper
• Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline.

  2010cites this paper
• Stimulation of both estrogen and androgen receptors maintains skeletal muscle mass in gonadectomized male mice but mainly via different pathways.

  2010cites this paper
• Self-reported psychological distress associated with steroid therapy for HIV

  2010cites this paper
• Testosterone Therapy for Osteoporosis in Men

  2010cites this paper
• Liquid chromatography-tandem mass spectrometry applications in endocrinology.

  2009cites this paper
• Anabolic applications of androgens for functional limitations associated with aging and chronic illness.

  2009cites this paper
• Testosterone replacement therapy

  2009cites this paper
• New insights into the role of anabolic interventions in dialysis patients with protein energy wasting

  2009cites this paper
• Anabolic steroids: dependence and complications of chronic use

  2009cites this paper
• Mass Spectrometric Applications for Diagnosing Metabolic and Endocrine Diseases

  2008cites this paper
• Concerning "Effects of a supraphysiological dose of testosterone on physical function, fatigue, and mood in men with human immunodeficiency virus-associated weight loss".

  2008cites this paper
• For information on reprint requests of more than 101 and commercial reprints contact

  2008cites this paper
• Effects of a Supraphysiologic Dose of Testosterone on Physical Function, Muscle Performance, Mood, and Fatigue in Men with Human Immunodeficiency Virus Associated Weight Loss

  2008cites this paper
• Genetic resistance to infection influences a male's sexual attractiveness and modulation of testosterone.

  2008cites this paper
• Effects of a supraphysiological dose of testosterone on physical function, muscle performance, mood, and fatigue in men with HIV-associated weight loss.

  2008cites this paper
• Nutritional Support for the Cancer Patient

  2006cites this paper
• Testosterone therapy in adult men with androgen deficiency syndromes: an endocrine society clinical practice guideline.

  2006cites this paper
• Aging and HIV Infection

  2006cites this paper
• ESPEN Guidelines on Enteral Nutrition: Wasting in HIV and other chronic infectious diseases.

  2006cites this paper
• Effects of nandrolone decanoate compared with placebo or testosterone on HIV‐associated wasting

  2006cites this paper
• Oxandrolone in the Treatment of HIV-Associated Weight Loss in Men: A Randomized, Double-Blind, Placebo-Controlled Study

  2006cites this paper
• The molecular mechanisms of skeletal muscle wasting: implications for therapy.

  2006cites this paper
• Drug Insight: testosterone and selective androgen receptor modulators as anabolic therapies for chronic illness and aging

  2006cites this paper
• Counteracting muscle wasting in HIV‐infected individuals

  2006cites this paper
• A randomized, placebo-controlled trial of nandrolone decanoate in human immunodeficiency virus-infected men with mild to moderate weight loss with recombinant human growth hormone as active reference treatment.

  2005cites this paper
• Androgens, Anabolic Steroids, and Glucocorticoids

  2005cites this paper
• Nutritional considerations in the use of ART in resource-limited settings Consultation on Nutrition and HIV/AIDS in Africa: Evidence, lessons and recommendations for action

  2005cites this paper
• Treatment with nandrolone decanoate and megestrol acetate in HIV-infected men.

  2005cites this paper
• Monitoring insulin-like growth factors in HIV infection and AIDS.

  2005cites this paper
• Effects of testosterone replacement in human immunodeficiency virus-infected women with weight loss.

  2005cites this paper
• Conceptos actuales y nuevas terapéuticas para el síndrome de desgaste asociado con el virus de la inmunodeficiencia humana

  2005cites this paper
• Hypogonadism in Men With HIV-AIDS

  2004cites this paper
• Male Hypogonadism

  2004cites this paper
• Efficacy of Selected Treatments of HIV Wasting: A Systematic Review and Meta-Analysis

  2004cites this paper
• Topical testosterone treatment for chronic allograft failure in liver transplant recipients with recurrent hepatitis C virus.

  2004cites this paper
• Testosterone action on skeletal muscle

  2004cites this paper
• Oxymetholone for the treatment of HIV-wasting: a double-blind, randomized, placebo-controlled phase III trial in eugonadal men and women.

  2003cites this paper
• HIV and testosterone therapy.

  2003cites this paper
• Role of testosterone in maintaining lean body mass and bone density in HIV-infected patients

  2003cites this paper
• Understanding and managing cancer cachexia.

  2003cites this paper
• “Non-thyroidal illness syndrome” is functional central hypothyroidism, and if severe, hormone replacement is appropriate in light of present knowledge

  2003cites this paper
• Heated amphotericin to treat leishmaniasis.

  2003cites this paper
• TRACE: Tennessee Research and Creative TRACE: Tennessee Research and Creative Exchange Exchange

  year unknowncites this paper